ClinicalTrials.gg
CompletedNCT07528482Updated Oct 21, 2026

Effects of Reflexology and Cold Application Before Chest Tube Removal in CABG Patients

An interventional study of Reflexology and Cryotherapy alone in Pain, Acute Post-Operative, Anxiety and Chest Tube Removal, sponsored by Ankara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Ankara University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Dec 2025, registered Apr 2026).
Updated Oct 21, 2026Now CompletedPrimary completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Pain, Postoperative by Ankara University — 3 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Ankara University.

Enrollment
3rd of 14
108 · median 78
Started
2025
with 3 others
No phase
11 of 15
3 open now
Registered
13th of 15
by date

Among the 15 studies in Pain, Postoperative by Ankara University, this one is the 3rd largest by enrollment of the 14 interventional ones that give a count, is one of 4 that started in 2025, is one of 11 with no phase, and was the 13th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

3 of the 15 studies in Pain, Postoperative by Ankara University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Pain, Postoperative by Ankara University, or all of them as a file.
02

Study summary

This randomized controlled trial evaluated the effects of foot reflexology and cold application, administered separately before chest tube removal, on pain, state anxiety, and physiological parameters in patients following coronary artery bypass graft (CABG) surgery. A total of 108 patients were assigned to a foot reflexology group, a cold application group, or a control group receiving routine care. Outcomes were assessed before the intervention, immediately before chest tube removal, and 30 minutes after removal. The study compared changes in these outcomes across the three groups.

Read the detailed description

Detailed Description This three-arm, parallel-group randomized controlled trial evaluated the effects of foot reflexology and cold application administered before chest tube removal on pain, state anxiety, and physiological parameters in patients following coronary artery bypass graft (CABG) surgery.

A total of 108 patients were randomized in a 1:1:1 ratio to the foot reflexology, cold application, or control group, with 36 participants in each group. Participants received a single 20-minute session of foot reflexology (10 minutes per foot), a 20-minute cold application using a 13 × 13 cm cold gel pack placed over gauze on the dressing around the chest tube, or a 20-minute rest period with routine clinical care and no additional nonpharmacological intervention, respectively. Chest tube removal was performed using the same standard clinical procedure in all groups.

Data were collected using a Patient Demographic Information Form, the Visual Analog Scale (VAS) for pain, the State-Trait Anxiety Inventory-State subscale (STAI-I), and a Vital Signs Monitoring Form. Pain, state anxiety, systolic and diastolic blood pressure, pulse rate, respiratory rate, and oxygen saturation were assessed at baseline before the intervention (T1), immediately after the intervention and before chest tube removal (T2), and 30 minutes after removal (T3).

The primary outcome was the VAS pain score at T3. Pain and state anxiety were analyzed using mixed-design ANCOVA, with the corresponding baseline score included as a covariate. Physiological parameters were analyzed using a three-group-by-three-time mixed-design ANOVA. The study assessed whether changes in pain, state anxiety, and physiological parameters differed among the three groups over time.

03

Conditions studied

  • Pain, Acute Post-Operative
  • Anxiety
  • Chest Tube Removal
  • Coronary Artery Bypass

Keywords

  • Reflexology
  • Cold Application
  • Chest Tube Removal Pain
  • Non-pharmacological Interventions
  • Nursing Care
04

Who can participate

The criteria were revised on the registry on Oct 21, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria

Aged 18 years or older Undergoing chest tube removal following first-time coronary artery bypass graft (CABG) surgery No history of previous open-heart surgery No systemic analgesic use within 4 hours before the intervention Able to communicate and oriented Willing to participate voluntarily and able to provide written Exclusion Criteria

Hemodynamic instability or use of inotropic medication History of chronic pain History of alcohol or substance abuse or dependence A diagnosed psychiatric disorder that could affect communication or the ability to complete the study scales Foot lesions, neuropathy, peripheral vascular disease, infection, burns, or open wounds that could prevent reflexology Lower-extremity amputation Local infection or an open wound at the chest tube insertion site that could prevent cold application

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (actual)

Study arms

  • Experimental
    Reflexology Group

    Participants in this group received foot reflexology for 20 minutes (10 minutes per foot) before chest tube removal.

    Behavioral: Reflexology

  • Experimental
    Cold Application Group

    Participants in this group received a 20-minute cold application using a 13 × 13 cm cold gel pack wrapped in gauze and placed over the dressing around the chest tube before removal.

    Behavioral: Cryotherapy alone

  • No intervention
    Control Group

    Patients in this group will receive standard clinical care and monitoring, with no additional interventions.

Interventions

  • BehavioralReflexology

    A trained researcher will apply foot reflexology for 40 minutes (20 minutes per foot) prior to chest tube removal. The intervention focuses on specific reflex points on the soles, dorsum, and toes of both feet to reduce pain and anxiety

  • BehavioralCryotherapy alone

    A 13 cm x 13 cm cold pack, frozen for at least 2 hours at -20°C/-30°C, will be applied to the skin at the chest tube insertion site for 20 minutes before removal. The area will be covered with a gauze pad to prevent direct contact with the skin

06

What researchers measure

Primary outcomes

  1. Pain intensity 30 minutes after chest tube removal

    Pain intensity was measured using a 10-cm Visual Analog Scale (VAS), ranging from 0 ("no pain at all") to 10 ("unbearable pain"). Higher scores indicate greater pain intensity.

    Time frame: 30 minutes after chest tube removal (T3).

Secondary outcomes

  1. State anxiety score

    State anxiety was assessed using the State Anxiety subscale of the State-Trait Anxiety Inventory (STAI-I), a 20-item scale with total scores ranging from 20 to 80. Higher scores indicate greater state anxiety.

    Time frame: At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).

  2. Physiological Parameters (Systolic Blood Pressure)

    Systolic blood pressure was measured in mmHg using a standard bedside monitor.

    Time frame: At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).

  3. Physiological Parameters (Diastolic Blood Pressure)

    Diastolic blood pressure will be measured in mmHg using a non-invasive blood pressure monitor.

    Time frame: Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3).

  4. Physiological Parameters (Pulse rate)

    Heart rate will be measured in beats per minute (bpm) using a pulse oximeter or cardiac monitor.

    Time frame: Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3).

  5. Respiratory Rate

    Respiratory rate was monitored using a standard bedside monitor and recorded in breaths per minute.

    Time frame: At baseline before the intervention (T1), immediately after the 20-minute intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).

  6. Oxygen Saturation (SpO2) (%)

    Oxygen saturation will be measured as a percentage (%) using a non-invasive pulse oximeter device attached to the patient's finger.

    Time frame: Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3).

07

Study locations

1 site
  • Gulhane Training and Research Hospital
    Ankara, Ankara 06010, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to protect participant privacy and confidentiality.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Apr 2026, 3 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 3 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

Primary completion moved once since we started tracking on Sep 25, 2026: May 2026 → Apr 2026, on Oct 21, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 4, 2026
First posted
Apr 14, 2026
StartActual
Dec 15, 2025
Primary completionActual
Apr 8, 2026was May 2026
CompletionActual
May 4, 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 21, 2026
Sites
1 site added, 1 site removed
Show site
  • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
Show 1 removed
  • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
Oct 21, 2026
Primary completion
May 4, 2026→Apr 8, 2026 (actual)
Oct 21, 2026
Eligibility
5 inclusion criteria removed; 6 exclusion criteria removed; 3 criteria added
What changed in the criteria
  • AddedInclusion Criteria
  • AddedAged 18 years or older Undergoing chest tube removal following first-time coronary artery bypass graft (CABG) surgery No history of previous open-heart surgery No systemic analgesic use within 4 hours before the intervention Able to communicate and oriented Willing to participate voluntarily and able to provide written informed consent Exclusion Criteria
  • AddedHemodynamic instability or use of inotropic medication History of chronic pain History of alcohol or substance abuse or dependence A diagnosed psychiatric disorder that could affect communication or the ability to complete the study scales Foot lesions, neuropathy, peripheral vascular disease, infection, burns, or open wounds that could prevent reflexology Lower-extremity amputation Local infection or an open wound at the chest tube insertion site that could prevent cold application
Inclusion criteria
  • RemovedBeing 18 years of age or older
  • RemovedNot having undergone previous open heart surgery
  • RemovedNot having received analgesics within 4 hours prior to the procedure
  • RemovedHaving a VAS pain score of 3 or higher
  • RemovedVoluntary participation in the study
Exclusion criteria
  • RemovedBeing under 18 years of age
  • RemovedUsing inotropic drugs
  • RemovedHaving a history of chronic pain
  • RemovedHaving a history of alcohol or drug use
  • RemovedHaving a psychiatric illness
  • RemovedHaving skin lesions, burns, or wounds on the feet that would prevent massage application
Oct 21, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Severity of Post-Procedural PainNow Pain intensity 30 minutes after chest tube removalTime frame: Baseline (T1: initial), pre-procedure after intervention (T2: 40 minutes after initial), and 30 minutes post-procedure (T3). → 30 minutes after chest tube removal (T3).
Oct 21, 2026
Secondary outcomes
2 edited, 2 time frame changed, 2 description edited
What changed in the outcomes
  • EditedState Anxiety Levelanxiety scoreTime frame: 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
  • EditedPhysiological Parameters (Heart RatePulse rate)Time frame: Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3).
  • Time framePhysiological Parameters (Systolic Blood Pressure)Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
  • Time frameRespiratory RateBaseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the 20-minute intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
  • DescriptionPhysiological Parameters (Systolic Blood Pressure): how it is measured was reworded
  • DescriptionRespiratory Rate: how it is measured was reworded
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
    Show 1 removed
    • Gulhane Training and Research Hospital · Ankara, Turkey (Türkiye)
    Primary completion May 4, 2026→Apr 8, 2026 (now actual)
    Eligibility 5 inclusion criteria removed; 6 exclusion criteria removed; 3 criteria added
    What changed in the criteria
    • AddedInclusion Criteria
    • AddedAged 18 years or older Undergoing chest tube removal following first-time coronary artery bypass graft (CABG) surgery No history of previous open-heart surgery No systemic analgesic use within 4 hours before the intervention Able to communicate and oriented Willing to participate voluntarily and able to provide written informed consent Exclusion Criteria
    • AddedHemodynamic instability or use of inotropic medication History of chronic pain History of alcohol or substance abuse or dependence A diagnosed psychiatric disorder that could affect communication or the ability to complete the study scales Foot lesions, neuropathy, peripheral vascular disease, infection, burns, or open wounds that could prevent reflexology Lower-extremity amputation Local infection or an open wound at the chest tube insertion site that could prevent cold application
    Inclusion criteria
    • RemovedBeing 18 years of age or older
    • RemovedNot having undergone previous open heart surgery
    • RemovedNot having received analgesics within 4 hours prior to the procedure
    • RemovedHaving a VAS pain score of 3 or higher
    • RemovedVoluntary participation in the study
    Exclusion criteria
    • RemovedBeing under 18 years of age
    • RemovedUsing inotropic drugs
    • RemovedHaving a history of chronic pain
    • RemovedHaving a history of alcohol or drug use
    • RemovedHaving a psychiatric illness
    • RemovedHaving skin lesions, burns, or wounds on the feet that would prevent massage application
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Severity of Post-Procedural PainNow Pain intensity 30 minutes after chest tube removalTime frame: Baseline (T1: initial), pre-procedure after intervention (T2: 40 minutes after initial), and 30 minutes post-procedure (T3). → 30 minutes after chest tube removal (T3).
    Secondary outcomes 2 edited, 2 time frame changed, 2 description edited
    What changed in the outcomes
    • EditedState Anxiety Levelanxiety scoreTime frame: 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
    • EditedPhysiological Parameters (Heart RatePulse rate)Time frame: Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3).
    • Time framePhysiological Parameters (Systolic Blood Pressure)Baseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
    • Time frameRespiratory RateBaseline (T1), pre-procedure (T2), and 30 minutes post-procedure (T3). → At baseline before the intervention (T1), immediately after the 20-minute intervention or waiting period and before chest tube removal (T2), and 30 minutes after chest tube removal (T3).
    • DescriptionPhysiological Parameters (Systolic Blood Pressure): how it is measured was reworded
    • DescriptionRespiratory Rate: how it is measured was reworded
    + 6 other changes: identifiers, verification date, description, design details, arm descriptions and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07528482
Lead sponsor
Ankara University
Responsible party
Neriman Yükseltürk Simşek (assistant prof, Ankara University) — Principal investigator
First posted
Apr 14, 2026
Start date
Dec 15, 2025
Primary completion
Apr 8, 2026
Completion
May 4, 2026
Last update
Oct 21, 2026

Study contacts

neriman yükseltürk şimşek, assistant prof
principal investigator · ankara u
yasemin özkan
study chair · Gulhane Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion